Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,325 public trials 1,974 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

Intratumoral N17350 in Advanced Solid Tumors

NCT07339176

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Triple-Negative, +33 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700

Conditions
Breast Diseases, Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0066) Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center ( Site 0034) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0035) Tucson, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center ( Site 0055) Burbank, California, United States
View all 317 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

NCT06369285

Conditions
Breast Diseases, Breast Neoplasms, Hormone Receptor Positive HER-2 Negative Breast Cancer, +6 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
View all 53 locations
View Trial Details
Recruiting

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT06184750

Conditions
Adenocarcinoma, Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, +17 more
Locations
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Illinois College of Medicine - Chicago Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

NCT06393374

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Infirmary Cancer Care ( Site 0001) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers-Research ( Site 0054) Chandler, Arizona, United States
  • MemorialCare Orange Coast Medical Center ( Site 9501) Fountain Valley, California, United States
  • Scripps Cancer Center ( Site 0052) La Jolla, California, United States
View all 306 locations
View Trial Details

Related conditions